
|Videos|August 20, 2018
Perspective on the Treatment of Advanced Renal Cell Cancer
Perspective on the Treatment of Advanced Renal Cell Cancer
Advertisement
A Japanese-American Male With Recurrent RCC
November 2015
- At the age of 49, a Japanese-American man presented to the ER with abdominal pains
- CT of the abdomen and pelvis revealed diverticulitis with an incidental left renal mass (4.2 cm × 8.6 cm × 2.8 cm)
- SH: Marathon runner; nonsmoker; social drinker
- He underwent sigmoid colon resection; left radical nephrectomy
- Pathology; sigmoid colon pathology revealed diverticulitis; renal pathology revealed RCC, clear cell type
- Diagnosis: RCC stage PT2a
- KPS: 90
- Fuhrman Grade: 3/4
September 2017
- Follow-up CT showed residual soft tissue in the left nephrectomy bed, pulmonary lung metastasis, and an expansile lucent osseous lesion in the right pubic ramus
- Biopsy of one of the osseous lesions confirmed mRCC
- He began systemic therapy with sunitinib for 20 weeks and achieved stable disease and some shrinkage of the bone lesion
- KPS: 90
- MSKCC risk score: Intermediate
July 2018
- The patient now complains of left pelvic pain
- Imaging shows marked progression in retroperitoneal mass; new lung metastasis
- Laboratory values:
- CBC: WBC - 7; Hgb - 12.6; Platelet - 190; ANC 5.2;
- CMP; Creatinine - 1.82 mg/dL; LFTs - WNL; Calcium - 9.2 mg/dL; LDH WNL
- MSKCC risk score: Intermediate
- KPS: 80
- The patient was treated with palliative radiation therapy to bone metastasis
- He was then started on treatment with lenvatinib/everolimus
Advertisement
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL
2
Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC
3
JANX007 Shows Promising Efficacy, Safety in Phase 1 Trial Update
4
LP-184 Demonstrates Favorable Efficacy and Safety in Advanced Solid Tumors
5









































